Liquid Biopsy Market 2019-2026 by Top Key Players- Qiagen N.V., Trovagene, Inc, Janssen Global Services, LLC, Silicon Biosystems, Sysmex Corporation, Natera, Inc

1
Liquid Biopsy Market 2019-2026 by Top Key
Players- Qiagen N.V., Trovagene, Inc, Janssen
Global Services, LLC, Silicon Biosystems, Sysmex
Corporation

• Apr 2021

Report Id REP-GB-1396 Published On
17-Jan-2020 Category Healthcare,
Pharmaceuticals Medical Devices
2
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage

• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research

• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment

• Chemicals Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email hari.t_at_futuremarketinsights.co
m
3
Research Methodology (1/2)

• Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)

• Identifying key opinion leaders
• Questionnaire design
• In-depth interviews
• Coverage across value chain

• Key industry experts
• Channel study
• Developments
• Market dynamics
• Products
• Conclusions

SOLUTION

• Market participants
• Key strengths
• Product portfolio
• Mapping as per value chain
• Key focus segments

Primary Research
Secondary Research
Paid Publications

• Linkedin
• Zoominfo
• Salesforce
• Avention

• Factiva
• GBI
• Genios
• Meltwater

• Company websites
• Company annual reports
• White papers
• Financial reports

includes sources of databases
4
Liquid Biopsy Market Analysis
This report by Future Market Insights (FMI)
examines the Liquid Biopsy Market for the
period 20162026. The primary objective of the
report is to offer updates and information
related to market opportunities in the global
liquid biopsy market. Report Description The
global liquid biopsy market report begins by
defining liquid biopsy and various types of
markers used in liquid biopsy. It is followed by
an overview of market dynamics of the global
liquid biopsy market, which includes FMIs
analysis of key trends, drivers, restraints and
opportunities, and reimbursement scenario that is
influencing the growth of the liquid biopsy
market. It also includes an insight into
case-studies and product pipeline. Impact
analysis of key growth drivers and restraints
based on a weighted average model have been
included in the global liquid biopsy market
report after detailed analysis of individual
regions to better equip readers with meaningful
insights on ongoing developments in the oncology
market. The primary factors fuelling demand for
liquid biopsy diagnostic tests are growing
incidences of lung, gastrointestinal and breast
cancer. Other factors driving demand for liquid
biopsy tests are increasing inclination of
oncologists and physician to opt for non-invasive
diagnostic procedures.
5
Liquid Biopsy Market Analysis
Reluctance of the patients to go painful biopsies
and increase in the demand of personalized
medicine. Request a Sample of this Report _at_
https//www.futuremarketinsights.com/reports/sampl
e/rep-gb-1396 Whereas increasing number of test
launches and entry of regional players also
drives the market for liquid biopsy tests.
However, a primary factor hampering growth of the
liquid biopsy market is its penetration owing
lower awareness of blood tests to detect
cancer. Based on market type, the market has been
segmented into circulating tumour cells (CTCs),
Circulating tumour Nucleic Acids (ctNA) and
exosomes. A detailed analysis has been provided
for these segment in terms of market size, Y-o-Y
growth rate, absolute opportunity and BPS
analysis. Based on sample type, the market has
been segmented into blood, urine and others
(plasma, saliva, CSF). Our analysis predicts that
biopsies through blood samples would increase at
a very fast pace, increasing the number of blood
diagnostic test to detect cancer is expected to
contribute significantly to increasing demand for
liquid biopsies the forecast period.
6
Liquid Biopsy Market Analysis
Based on the disease indication the liquid biopsy
market has been segmented into lung cancer,
gastrointestinal cancer, prostate cancer, breast
cancer, colorectal cancer, leukemia and others. 
Lung cancer is expected to expand at a higher
CAGR, due to increasing prevalence of lung cancer
over the forecast period. Further, based on
end-user segmentation, the market is segmented
into hospitals, cancer institutes, academic
institutes and diagnostic centres. Increasing
commercialization of liquid biopsy test is
expected to increase the revenue generation of
liquid biopsies from hospitals and diagnostic
centres surgery. This trend is expected to be
particularly prominent in countries where access
to healthcare services is increasing especially
in APEJ The next section of the report highlights
liquid biopsy market by region and provides
market outlook for 20162026. The report also
discusses key regional trends contributing to the
revenue growth of the liquid biopsy tests
worldwide, as well as analyses the impact of
drivers and restraints in each region. Key
regions assessed in this report include North
America, Latin America, Western Europe, Eastern
Europe, Asia Pacific Excluding Japan (APEJ),
Japan and Middle East Africa (MEA).
7
Liquid Biopsy Market Analysis
The above sectionsby marker type, sample type,
disease indication, end users and regionevaluate
the present scenario and growth prospects of the
liquid biopsy tests market for 20162026. We have
considered 2015 as the base year and provided
data for the forecast period, i.e., 20162026. To
ascertain liquid biopsy tests market size, we
have also considered revenue generated by
companies in liquid biopsy market space. The
forecast presented here assesses the total
revenue by value across the liquid biopsy market.
In order to offer an accurate forecast, we
started by sizing up the current market, which
forms the basis of how the liquid biopsy market
is expected to develop in the future. Given the
characteristics of the market, we triangulated
the outcome of three different types of analysis
based on supply side, downstream industry demand,
and the economic envelope. In addition, it is
imperative to note that in an ever-fluctuating
global economy, we not only conduct forecasts in
terms of CAGR, but also analyse it based on key
parameters such as year-on-year (Y-o-Y) growth
rates to understand the predictability of the
market, and to identify the right opportunities
across the global liquid biopsy market.
8
Liquid Biopsy Market Analysis
The liquid biopsy market segments in terms of
marker type, sample type, disease indication, end
user, and regions. These segments are analysed in
terms of Basis Point Share (BPS) to understand
individual segments relative contributions to
market growth. This detailed level of information
is important for identifying various key trends
in the liquid biopsy market. Get Full Report Buy
Now _at_ https//www.futuremarketinsights.com/checkou
t/1396 Another key feature of this report is
the analysis of key segments in terms of absolute
dollar opportunity. This is overlooked while
forecasting the market. However, absolute dollar
opportunity is critical for assessing the level
of opportunity that a provider can look to
achieve, as well as to identify potential
resources from a sales and delivery perspective,
in the global liquid biopsy market. To understand
key growth segments in terms of growth and
adoption for liquid biopsy tests globally, Future
Market Insights developed the liquid biopsy
market Attractiveness Index. The resulting
index is expected to help providers identify real
market opportunities in the overall oncology
market. Key Segments Covered
9
Liquid Biopsy Market Analysis

• By Marker Type
• CTCs (Circulating tumour Cells)
• ctNA (Circulating tumour Nucleic Acids)
• Exosomes
• By Sample Type
• Blood
• Urine
• Others (Plasma, Saliva, CSF)
• By Disease Indication
• Lung Cancer
• Gastrointestinal Cancer
• Prostate Cancer
• Breast Cancer
• Colorectal Cancer
• Leukemia
• Others

10
Liquid Biopsy Market Analysis

• By End-User
• Hospitals
• Cancer Institutes
• Academic Institutes
• Diagnostic Centers
• Key Regions/Countries Covered
• North America
• Latin America
• Western Europe
• Eastern Europe
• Asia Pacific Ex. Japan (APEJ)
• Japan
• Middle East Africa
• Key Companies
• BIOCEPT, INC.
• Qiagen N.V.
• Trovagene, Inc.

11
Liquid Biopsy Market Analysis

• Janssen Global Services, LLC
• MDxHealth SA
• Natera, Inc.
• Hoffmann-La Roche Ltd.
• Silicon Biosystems
• Pathway Genomics Corporation
• Sysmex Corporation
• Request for Report Ask A Question _at_
  https//www.futuremarketinsights.com/ask-question/
  rep-gb-1396
• In the final section of the report on the global
  liquid biopsy market, Competitive Landscape is
  included to provide report audiences with a
  dashboard view, based on categories of test
  developers in the liquid biopsy market space and
  key differentiators. Key categories of providers
  covered in the report are companies developing
  liquid biopsy tests. This section is primarily
  designed to provide clients with an objective and
  detailed comparative assessment of key providers
  specific to a market segment in the liquid biopsy
  value chain and the potential players for the
  same. Report audiences can gain segment-specific
  company insights to identify and evaluate key
  competitors based on in-depth assessment of
  capabilities and successes in liquid biopsy
  marketplace.

12
Liquid Biopsy Market Analysis
Detailed profiles of the liquid biopsy tests
developing companies are also included in the
scope of the report to evaluate their long- and
short-term strategies, key offerings, SWOT
analysis, and recent developments in the global
liquid biopsy market. Key competitors covered in
terms of liquid biopsy test developing companies
BIOCEPT, INC., Qiagen N.V., Trovagene, Inc.,
Janssen Global Services, LLC, MDxHealth SA,
Natera, Inc., F. Hoffmann-La Roche Ltd., Silicon
Biosystems, Pathway Genomics Corporation, Sysmex
Corporation.
For more insights on the Liquid Biopsy
Market,you can request a report sample with full
TOC
13
To know more about us, please visit our website
www.futuremarketinsights.com For sales queries
or new topics email us on sales_at_futuremarketinsi
ghts.com For media queries, contact the press
office at press_at_futuremarketinsights.com For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email hari.t_at_futuremarketinsights.com
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)